hematological malignancies

https://www.oncotarget.com/article/7772/text/ Notch signaling: its roles and therapeutic potential in hematological malignancies | Oncotarget https://doi.org/10.18632/oncotarget.7772 Yisu Gu, Massimo Masiero, Alison H. Banham notch signaling therapeutic potential hematological malignancies roles https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1283831/full Frontiers | Characteristics of patients with newly diagnosed hematological malignancies referred... ObjectiveThe importance of cardio-hemato-oncology programs is increasing. The main aim of the study was to identify all coexisting cardiovascular disorders i... newly diagnosed hematological malignancies frontiers characteristics patients https://pubmed.ncbi.nlm.nih.gov/32822769/ Association between Toxoplasma gondii exposure and hematological malignancies: A systematic review... The possible association between Toxoplasma gondii infection and hematological malignancies has been suggested by several studies. The current systematic... toxoplasma gondii hematological malignancies association exposure https://cordis.europa.eu/project/id/101097026/es Early detection and screening of hematological malignancies | SANGUINE | Proyecto | Ficha... Project SANGUINE addresses the objectives raised by the Cancer Mission Call, which emerged from the growing societal challenge faced by European citizens.... early detection hematological malignancies screening sanguine proyecto https://haematologica.org/article/view/6614 Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines... diagnosis and treatment in patients hematological malignancies mucormycosis https://researchportal.murdoch.edu.au/esploro/outputs/journalArticle/TRPV1-channels-in-immune-cells-and/991005541558507891?institution=61MUN_INST&skipUsageReporting=true&recordUsage=false TRPV1 channels in immune cells and hematological malignancies - Murdoch University Transient receptor potential vanilloid-1 (TRPV1) is a member of the TRP family of channels that are responsible for nociceptive, thermal, and mechanical... immune cells hematological malignancies channels murdoch university https://mediamedic.co/pomalidomide-enhances-car-t-therapy-effectiveness-in-hematological-malignancies-a-promising-synergy/ Pomalidomide Enhances CAR-T Therapy Effectiveness in Hematological Malignancies: A Promising... Jan 27, 2025 - Relapsed and refractory multiple myeloma (R/R MM) and B-cell leukemia/lymphoma with extramedullary disease (EMD) represent some of the most formidable... car t hematological malignancies pomalidomide enhances therapy https://veri.larvol.com/associations/ror1-expression_hematological-malignancies_cs5001 Hematological Malignancies - CS5001 - ROR1 expression - LARVOL VERI LARVOL VERI predictive biomarker evidence connecting Hematological Malignancies, CS5001, and ROR1 expression. hematological malignancies expression veri https://scienmag.com/tag/role-of-evs-in-hematological-malignancies/ role of EVs in hematological malignancies | Science hematological malignancies role evs science https://medwinpublishers.com/article-description.php?artId=9216 Medwin Publishers | Extracellular Vesicles in Hematological Malignancies:Communicators for... Sep 9, 2022 - Extracellular vehicles (EVs), the secret messengers of a cell, are cell-derived signaling vesicles present in most human fluids. They have been recently... extracellular vesicles hematological malignancies publishers communicators https://accscience.com/journal/EJMO/6/3/10.14744/ejmo.2022.67393 Role of Endothelial Cells in Hematological Malignancies AccScience Publishing is a publishing company based in Singapore. We have in our portfolio a range of high-quality, open-access, peer-reviewed journals and... endothelial cells role hematological malignancies https://www.oncotarget.com/article/7772/text/ Notch signaling: its roles and therapeutic potential in hematological malignancies | Oncotarget https://doi.org/10.18632/oncotarget.7772 Yisu Gu, Massimo Masiero, Alison H. Banham notch signaling therapeutic potential hematological malignancies roles https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1283831/full Frontiers | Characteristics of patients with newly diagnosed hematological malignancies referred... ObjectiveThe importance of cardio-hemato-oncology programs is increasing. The main aim of the study was to identify all coexisting cardiovascular disorders i... newly diagnosed hematological malignancies frontiers characteristics patients https://pubmed.ncbi.nlm.nih.gov/32822769/ Association between Toxoplasma gondii exposure and hematological malignancies: A systematic review... The possible association between Toxoplasma gondii infection and hematological malignancies has been suggested by several studies. The current systematic... toxoplasma gondii hematological malignancies association exposure https://cordis.europa.eu/project/id/101097026/es Early detection and screening of hematological malignancies | SANGUINE | Proyecto | Ficha... Project SANGUINE addresses the objectives raised by the Cancer Mission Call, which emerged from the growing societal challenge faced by European citizens.... early detection hematological malignancies screening sanguine proyecto https://haematologica.org/article/view/6614 Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines... diagnosis and treatment in patients hematological malignancies mucormycosis https://journal.hep.com.cn/currmedsci/EN/10.1007/s11596-011-0569-y TMTP1, a novel tumor-homing peptide, specifically targets hematological malignancies and their... TMTP1, a 5-amino acid peptide NVVRQ, obtained by using the flagella peptide library screening in our previous studies, can be used for the labeling of... a novel https://research.ajman.ac.ae/en/publications/car-engineered-nk-cells-a-promising-therapeutic-option-for-treatm/ CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies...

Robuta